Nexentis Technologies (NXTS) Cash & Current Investments (2018 - 2026)
Nexentis Technologies' Cash & Current Investments came in at $8.88 million for Q2 2026, up 160.5% from $3.41 million a year earlier.
Powered by 
Analysis
Nexentis Technologies (NXTS) Cash & Current Investments (2018 - 2026) Analysis & Trends
At the end of FY2025, Nexentis Technologies' Cash & Current Investments was $4.07 million, up 82.6% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of 75.7% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $2.23 million in FY2024 (-49.9%), $4.45 million in FY2023 (-22.0%), $5.7 million in FY2022 (-15.6%) and $6.75 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Cash & Current Investments since Q2 2021.
- Year-over-year, Cash & Current Investments increased in four of the last seven quarters, with growth averaging 46.4%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 160.5%), and the weakest in Q3 2023 (a decline of 71.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Nexentis Technologies | 1.18 Mn | -21.59 Mn | - | 8.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.88 Mn |
| Dec 31, 2025 | 4.07 Mn |
| Sep 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 2.75 Mn |
| Jun 30, 2024 | 4.47 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 4.45 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 2.97 Mn |
| Mar 31, 2023 | 4.60 Mn |
| Dec 31, 2022 | 5.70 Mn |
| Sep 30, 2022 | 6.69 Mn |
| Jun 30, 2022 | 4.38 Mn |
| Mar 31, 2022 | 5.64 Mn |
| Dec 31, 2021 | 6.75 Mn |
| Sep 30, 2021 | 7.77 Mn |
| Jun 30, 2021 | 9.31 Mn |
API Access
Nexentis Technologies Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NXTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NXTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NXTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();